A perfume endorsed by the Susan G. Komen for the Cure foundation has come under fire.
The "Promise Me" perfume is facing accusations that certain incredients may be dangerous carcinogens that could cause cancer.
A group called "Breast Cancer Action" sent the perfume to be tested at Analytical Sciences, a California chemical lab.
A report on the test revealed it contained galaxolide, a synthetic musk that has been shown to accumulate in the body of women whose perfumes contained it, according to DailyFinance.com. The report goes on to allege that the ingredient may be a contributing factor in the development of breast cancer.
The Dallas-based Komen group said the accusations made aren't true and that it had scientists and health teams review every ingredient in the perfume — none of which, it says, are linked to cancer in humans.
DailyFinance said the perfume will be reformulated without certain ingredients being criticized.
The perfume, which runs about $60 a bottle, was first released in 2001.